Panel Discussion: Driving the Expansion of Comprehensive Genetic Testing to Expedite the Onset of Treatment for ALS Gene Carriers

Time: 4:30 pm
day: Day One PM


  • Highlighting the significant proportion of people at risk of genetic ALS and the urgency to streamline systematic genetic testing
  • Addressing disparities in testing accessibility among different doctors, clinics, and health insurances
  • Developing the framework for digital, cost-effective, and easily translatable platforms to monitor gene carriers over time